将血友病转变为护理:对新疗法选择的洞察力
Iasmina-Maria Iurea1, Emilia Severin1, Alexandra Matei1
1Genetics Department, Carol Davila University of Medicine and Pharmacy, Dionisie Lupu 37 Street, 020021 Bucharest, Romania.
Life (Basel, Switzerland)
|January 8, 2025
概括
本综述涵盖A型血友病,这是一种因 VIII 因子较低而引起的出血疾病. 它强调了新的基因疗法和全球获得护理的需要,以改善患者的治疗结果.
科学领域:
- 血液学 血液学 血液学
- 遗传学 遗传学 是一个
- 公共卫生 公共卫生
背景情况:
- 血友病A是一种遗传性出血障碍,由 VIII 凝固因子的缺乏引起.
- 它导致严重的发病率和受影响个体的生活质量下降.
研究的目的:
- 为血友病A提供最新的概述,包括其遗传基础和治疗进展.
- 讨论基因治疗的最新发展及其长期解决方案的潜力.
- 为改善患者的治疗结果,解决全球护理差异和政策影响.
主要方法:
- 使用多个数据库进行了全面的文献审查.
- 选择并总结了专注于血友病A遗传学和治疗选择的相关研究.
主要成果:
- 基因治疗的最新进展为A型血友病提供了有希望的长期治疗解决方案.
- 在医疗保健方面存在重大的全球差异,需要政策变化和全面的医疗保健框架.
结论:
- 血友病A的不断变化的风景管理需要临床医生和政策制定者的最新知识.
- 公平获得护理对于改善全球血友病A患者的生活质量至关重要.
更多相关视频
相关概念视频
X-linked Traits
53.3K
In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
53.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
607
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
607
Gene Therapy
25.2K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.2K
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Disorders of Hemostasis
696
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
696


